Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2029-08-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the objective response rate following neoadjuvant therapy with volrustomig, paclitaxel, and carboplatin in previously untreated human papillomavirus (HPV)-negative locally advanced head and neck squamous cell carcinoma
.